Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-19

Clinical Trial Update: Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring reduced bleeding by omitting aspirin in patients with non-ST-elevation acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Non ST Segment Elevation Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN